Onconomics Plus is a one-stop solution for choosing personalized treatment plans. This test represents an evaluation of the chemosensitivity of conventional drugs as well as natural extracts. E.g. Curcumin. This means with this test; we can tell which chemotherapeutic agents work and which do not. On top of that, we will also know the tumor cell sensitivity to extracts. I.e. which natural supplements work, and which don’t. The test also gives insight into the effectiveness of cancer in heat and radiation treatments in combination with genetic information.
Onconomics Plus is a revolutionary test that evaluates the best targeted cancer treatment options tailored to the patient’s genetic profile and cancer condition. This deeper understanding empowers practitioners to craft a treatment plan tailored precisely to you – all through a convenient and non-invasive liquid biopsy. The test provides the following details:
This comprehensive test analyzes the effectiveness of various chemotherapeutic drugs, targeted therapies, and even natural substances on an individual patient’s cancer cells.
Onconomics Plus test provides information on cancer’s activity and treatment response by measuring the circulating tumor cells (CTC) count in the blood.
Each patient has a unique genetic and physiological expression of cancer cells, which determines how the cancer cells respond to treatment.
By analyzing the gene expression, we can tailor treatment protocols to each patient individually, and ensure personalized care that will maximize the outcomes.
Chemotherapy involves the use of different chemotherapeutic agents, some may be effective while others may not.
To find out if the chemotherapeutic agents work for each specific cancer of the patient, the Onconomics Plus test can be used.
Our comprehensive panel assesses over 50 chemotherapeutic agents, providing insights into their sensitivity or resistance and empowering patients to make informed decisions about treatment options.
Many natural substances are known to have cancer-targeting properties. However, not all substances work equally for every patient.
Onconomics panel tests over 50 natural substances to offer evidence-based recommendations on which ones are most likely to yield positive results for a patient’s cancer.
Reserve your 30-minute free consultation
Through a combination of three assessments, Onconomics Plus assesses the chemosensitivity of anti-cancer drugs, natural substances, and gene expression profiling.
Assist decision-making between doctor and patient on the best way forward and offer insightful treatment options.
The test empowers the patient with the knowledge to make informed decisions on which path to take. This would provide for the highest probability of success whilst minimizing guesswork as to what would fail vs which supplement or chemo would likely succeed.
Oncotrail has undergone rigorous evaluation to ensure high sensitivity and specificity, making it an invaluable tool for diagnostic purposes.
Through high-precision techniques, the test is used to monitor the effectiveness of a particular cancer treatment. This would objectively provide information on how well the treatment is going.
The non-invasive tracking of the cancer status would notify a treating physician whether to adjust current management or stay the course. This would be important to know in almost real-time rather than to find out much later that a treatment doesn't apply to a particular person.
Whole peripheral blood sample
15-25ml blood, minimum 400mg tissue
10-12 days in the lab
21 days after sample collection
Applicable for all cancer types
To whom it is relevant: The test is useful for patients looking to decide on the right treatment or monitor their response.
A patient-centric revolution in cancer testing and monitoring. We are devoted to providing personalized tests designed with each patient’s unique genetic profile in mind.
©2024 All Rights Reserved. Designed by Bee High Media.
